In support of this hypothesis, AChE inhibitors have shown benefits in Alzheimer’s and Parkinson’s disease patients [28, 29], and reduced mitophagy contributes to mitochondrial dysfunction in many neurodegenerative diseases, including A-T [8, 40, 41]. This evidence concerns the gene ACHE and Parkinson disease.